Cargando…
Detection of the Ovarian Cancer Biomarker Lysophosphatidic Acid in Serum
Lysophosphatidic acid (LPA) is present during the medical condition of ovarian cancer at all stages of the disease, and, therefore possesses considerable potential as a biomarker for screening its presence in female patients. Unfortunately, there is currently no clinically employable assay for this...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168251/ https://www.ncbi.nlm.nih.gov/pubmed/32075013 http://dx.doi.org/10.3390/bios10020013 |